Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Thomas L, Schwartz"'
Publikováno v:
Drugs in Context, Vol 8, Pp 1-7 (2019)
Post-traumatic stress disorder (PTSD) continues to make headlines given multiple military engagements across the world and civilian traumas, and resultant PTSD development continues at an even pace. Currently, antidepressant and cognitive-behavioral
Externí odkaz:
https://doaj.org/article/391726e9c7d245deafe504008b5d389b
Autor:
Molly R Belkin, Thomas L Schwartz
Publikováno v:
Drugs in Context, Pp 1-5 (2017)
Clonidine and guanfacine are alpha-2 receptor agonists that decrease sympathetic outflow from the central nervous system. Posttraumatic stress disorder (PTSD) is an anxiety disorder that is theorized to be related to a hyperactive sympathetic nervous
Externí odkaz:
https://doaj.org/article/8d7665b52c6240a28ca88ae4b116c560
Publikováno v:
Drugs in Context, Pp 1-7 (2016)
Objective: Comparison of the efficacy and tolerability of five newer anti-obesity medications to guide clinical decision making, examining bupropion–naltrexone combination, liraglutide, lorcaserin, orlistat, and phentermine–topiramate combination
Externí odkaz:
https://doaj.org/article/90bd7df493844fa68a3b02738f186cd2
Autor:
Daniel Santarsieri, Thomas L Schwartz
Publikováno v:
Drugs in Context, Pp 1-12 (2015)
Prescribing of antidepressant treatment (ADT) for major depressive disorder (MDD) has increased in quantity and popularity over the last two decades. This is likely due to the approval of safer medications, better education of clinicians and their pa
Externí odkaz:
https://doaj.org/article/1c40794a848d46e2ba461652f8f5aeea
Publikováno v:
Drugs in Context, Pp 1-10 (2014)
Tardive dyskinesia (TD) is a disfiguring side-effect of antipsychotic medications that is potentially irreversible in affected patients. Newer atypical antipsychotics are felt by many to have a lower risk of TD. As a result, many clinicians may have
Externí odkaz:
https://doaj.org/article/099bc6bedbb647e3b5ac9ff6b202e9fb
Autor:
Thomas L Schwartz, Viral Goradia
Publikováno v:
Drugs in Context, Pp 1-10 (2013)
This review explores basic sleep physiology, the mechanism of action for each class of hypnotic agents, their clinical application based on pharmacodynamic and pharmacokinetic factors, and potential pharmacologic sleep-inducing mechanisms of future h
Externí odkaz:
https://doaj.org/article/990beef9dcdf433392d1751c2ceaf852
Publikováno v:
Drugs in Context, Vol 9, Pp 1-11 (2020)
Drugs in Context
Drugs in Context
Antidepressant treatment has been evolving and changing since the 1950s following the discovery of the classic antidepressant treatments including tricyclic antidepressants and monoamine oxidase inhibitors. The heterogeneity of the disorder became ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb00d5286ce0a5c5a14b1c61badd280
https://www.drugsincontext.com/antidepressant-efficacy-and-side-effect-burden:-an-updated-guide-for-clinicians
https://www.drugsincontext.com/antidepressant-efficacy-and-side-effect-burden:-an-updated-guide-for-clinicians
Autor:
Thomas L. Schwartz, Jungjin Kim
Major depressive disorder (MDD) is frequently comorbid with other psychiatric disorders. Compared to patients with only MDD, these patients with co-occurring disorders are more likely to have greater symptom burden, poorer course, and outcome, adding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5454657e7d0b75edb38738a8b140cc31
https://doi.org/10.1016/b978-0-323-58131-8.00007-0
https://doi.org/10.1016/b978-0-323-58131-8.00007-0
Autor:
Fariya Ali, Ali Bani-Fatemi, Isabelle E. Bauer, Bernhard T. Baune, Venkat Bhat, Justin N. Chee, Amy Cheung, Alexandria S. Coles, Timothy M. Cooper, Oluwagbenga O. Dada, Vincenzo De Luca, Erin C. Dunn, Peter Giacobbe, Ariel Graff, Tracy L. Greer, Dan V. Iosifescu, Jeethu K. Joseph, Jungjin Kim, Yena Lee, Roger Chun Man Ho, Roger S. McIntyre, Tomas Melicher, Ying Meng, Karim Mithani, Marcellino Monda, Charles B. Nemeroff, Roy H. Perlis, Arvind Rajagopalan, Joshua D. Rosenblat, Marsal Sanches, Thomas L. Schwartz, Gaurav Singhal, Jair C. Soares, Mehala Subramaniapillai, Samia Tasmim, Karen Wang, Kevin Z. Wang, Min-Jung Wang, Hanjing Wu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3384ff76d9200fdace19c83843c9bf8f
https://doi.org/10.1016/b978-0-323-58131-8.01002-8
https://doi.org/10.1016/b978-0-323-58131-8.01002-8
Publikováno v:
Frontiers in Pharmacology, Vol 3 (2012)
The Dopamine Hypothesis of Schizophrenia is actively being challenged by the NMDA Receptor Hypofunctioning Hypothesis of Schizophrenia. The latter hypothesis may actually be the starting point in neuronal pathways that ultimately modifies dopamine pa
Externí odkaz:
https://doaj.org/article/d109005ad1da4e6c857d3724f6d2b6cc